TNM Classification of Malignant Tumours.

TNM MobileEdition delivers all necessary tumour staging information right to your PDA. TNM MobileEdition is an electronic version of the International Union Against Cancer's (UICC) global cancer staging standard, TNM Classification of Malignant Tumours, 5th Edition, for use directly on your Palm OS personal handheld computers, including PalmPilots, Visors, and Sony Cliés.

TNM MobileEdition includes the complete text of TNM Classification of Malignant Tumours, Fifth Edition, plus integrated, explanatory text from TNM Supplement, Second Edition. This application also introduces the first mobile, interactive tumour staging calculator that automatically stages the progress of disease after the physician enters the T, N, and M components for a given patient.

TNM MobileEdition will be an indispensable tool for all oncologists and other professionals who employ the TNM classification system in assessing the diagnosis, treatment, and prognosis of patients with cancer.

·Matches the standards outline in TNM Classification of Malignant Tumours, Fifth Edition (1997).

·Classification System is identical to the AJCC TNM system.

·Applicable for Palm Operating Systems only.

TNM Classification of Malignant Tumours

Fifth Edition

TNM is the most widely used system for classifying the extent of cancer spread. The Fifth Edition contains important new additions and modifications. Among these are:
* A revised classification of nasopharyngeal carcinoma reflecting the needs of radiotherapists
* A revised testis tumour classification that incorporates serum markers into staging
* A new classification of gestational trophoblastic tumours that combines anatomic with nonanatomic risk factors
* A new classification of fallopian tube carcinomas
* Important changes in the classification of prostate, bladder, and kidney tumours reflecting advances in urology
* Changes in the regional lymph node classification of gastric carcinoma
* Expansion of the soft tissue tumour classification

These and other changes will enhance the value of TNM in treatment planning and as a prognostic indicator.